Il-18 Binding Protein (Il-18bp) And Antibodies In Inflammatory Diseases

A 1. IL-18, antibody technology, applied in allergic diseases, antibodies, anti-inflammatory agents, etc., can solve problems such as excessive secretion of constitutive IL-18

Pending Publication Date: 2018-02-02
AB2 BIO
View PDF24 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

NLRC4 mutations also lead to co

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Il-18 Binding Protein (Il-18bp) And Antibodies In Inflammatory Diseases
  • Il-18 Binding Protein (Il-18bp) And Antibodies In Inflammatory Diseases
  • Il-18 Binding Protein (Il-18bp) And Antibodies In Inflammatory Diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[1117] a. Detection of free IL-18vs. complex IL-18 / IL-18BP

[1118] 1. Common detection of IL-18 in patients

[1119]Quantification of human IL-18 in patients was performed with an ELISA assay detecting total IL-18 (both free form and IL-18BP complex). This ELISA contained commercially available antibodies (see Table 1 below). The most common ELISA assay is performed with anti-IL-18 antibody pairs developed by Taniguchi et al. 1997 and sold by different suppliers, namely mouse mAb 125-2H as primary / capture antibody and rat mAb 159-12B As a secondary / chromogenic antibody.

[1120]

[1121]

[1122] 2. Estimation of Free IL-18 Levels

[1123] To date, there are no reports of measured levels of free IL-18. Free IL-18 estimates were made by extrapolation using the calculations described by Novick et al. 2004 (see below). The data compare the levels of IL-18 and IL-18BP in humans. In these studies, investigators used commercial monoclonal anti-IL-18 antibody 125-2H an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.

Description

technical field [0001] The present invention provides means and methods for the treatment of interleukin 18 (IL-18) related diseases and conditions, in particular means and methods for the treatment of Still's disease. In particular, the present invention discloses antibodies and IL-18 binding proteins (IL-18BP) that specifically bind free IL-18 for use in such therapy, and in assays for the quantification of free IL-18 in body fluids. Background technique [0002] Interleukin-18 (IL-18), also known as interferon-gamma inducible factor, is a cytokine produced by activated macrophages, Kupffer cells and other cells. IL-18 binds to the IL-18 receptor and induces cell-mediated immunity. Deficiency (eg, knockout) of the IL-18 cytokine receptor or IL-18 cytokine results in impaired natural killer (NK) cell activity and TH1 responses. In addition to its physiological role, IL-18 can also cause severe inflammatory diseases. For the purpose of early diagnosis of such disorders, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/395C07K16/24G01N33/68A61P11/00A61P19/02A61P29/00A61P1/00A61P35/02
CPCC07K16/244G01N33/6869G01N2333/54A61K2039/505C07K2317/30C07K2317/92C07K2317/76A61K38/1709A61K2039/545A61P1/00A61P1/04A61P11/00A61P17/00A61P19/02A61P19/06A61P27/02A61P27/06A61P29/00A61P35/02A61P37/02A61P43/00A61P7/00A61P9/00A61P9/04A61P3/10A61K39/00A61K39/395
Inventor G·德尔瓦尔E·席夫林
Owner AB2 BIO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap